Highlights Sedana Medical AB

Equities

SEDANA

SE0015988373

Real-time Estimate Cboe Europe Other stock markets 05:58:57 2024-05-17 am EDT			5-day change	1st Jan Change
23.12 ^SEK	-0.96%		+10.50%	-0.04%

Apr. 25	Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024
Apr. 25	Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US	Apr. 25	CI
Sedana Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Sedana Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Sedana Medical Seeks Pediatric Indication for Sedaconda Medical Device	Dec. 20	MT
Sedana Medical AB Files Submission for Paediatric Indication	Dec. 20	CI
Sedana Medical AB Announces the Main Results from the Paediatric Isocomfort Study	Nov. 16	CI
Sedana Medical AB Provides Earnings Guidance for the Year 2023	23-10-26	CI
Sedana Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Sedana Medical AB Announces Completion of Enrollment	23-10-23	CI
Sedana Medical AB Announces Medicines and Healthcare Products Regulatory Agency Grants Marketing Authorization for Sedaconda in United Kingdom	23-10-10	CI
Sedana Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-21	CI
Sedana Medical Slumps 35% as Submission of New Drug Application for Isoflurane Delayed	23-07-12	MT
Sedana Medical AB Informs About Adjusted US Submission Plan Following FDA Interaction	23-07-12	CI
Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Sedana Medical AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-16	CI
Sedana Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-16	CI
Sedana Medical Wins Italian Regulatory Nod for Inhaled Sedation Drug	23-02-07	MT
Sedana Medical AB Receives Market Approval for Sedaconda in Italy	23-02-07	CI
Sedana Medical Begins Trading on Nasdaq Stockholm After Listing Transfer	23-01-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sedana Medical AB

Equities

SEDANA

SE0015988373

Highlights

Filters